Freezing of gait: understanding the complexity of an enigmatic phenomenon

Brain. 2020 Jan 1;143(1):14-30. doi: 10.1093/brain/awz314.

Abstract

Diverse but complementary methodologies are required to uncover the complex determinants and pathophysiology of freezing of gait. To develop future therapeutic avenues, we need a deeper understanding of the disseminated functional-anatomic network and its temporally associated dynamic processes. In this targeted review, we will summarize the latest advances across multiple methodological domains including clinical phenomenology, neurogenetics, multimodal neuroimaging, neurophysiology, and neuromodulation. We found that (i) locomotor network vulnerability is established by structural damage, e.g. from neurodegeneration possibly as result from genetic variability, or to variable degree from brain lesions. This leads to an enhanced network susceptibility, where (ii) modulators can both increase or decrease the threshold to express freezing of gait. Consequent to a threshold decrease, (iii) neuronal integration failure of a multilevel brain network will occur and affect one or numerous nodes and projections of the multilevel network. Finally, (iv) an ultimate pathway might encounter failure of effective motor output and give rise to freezing of gait as clinical endpoint. In conclusion, we derive key questions from this review that challenge this pathophysiological view. We suggest that future research on these questions should lead to improved pathophysiological insight and enhanced therapeutic strategies.

Keywords: Parkinson’s disease; freezing of gait (FoG); genetics; neurophysiology; stimulation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Apolipoprotein E4 / genetics
  • Brain / diagnostic imaging
  • Brain / physiopathology*
  • Brain Mapping
  • Cytochrome P-450 CYP2D6 / genetics
  • Functional Neuroimaging
  • Gait Disorders, Neurologic / diagnostic imaging
  • Gait Disorders, Neurologic / genetics
  • Gait Disorders, Neurologic / physiopathology*
  • Glucosylceramidase / genetics
  • Humans
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / genetics
  • Magnetic Resonance Imaging
  • Mutation
  • Neural Pathways / physiopathology
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / genetics
  • Parkinson Disease / physiopathology*
  • Positron-Emission Tomography
  • Receptors, Dopamine D2 / genetics
  • Tomography, Emission-Computed, Single-Photon

Substances

  • Apolipoprotein E4
  • Receptors, Dopamine D2
  • Cytochrome P-450 CYP2D6
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Glucosylceramidase